Biomarkers for Allergen Immunotherapy in Cedar Pollinosis

Biomarkers for Allergen Immunotherapy in Cedar Pollinosis

To initiate, monitor, and complete effective immunotherapy, biomarkers to predict and visualize the immune responses are needed. First, we need to identify the right candidate for immunotherapy. Secondly, the immune responses induced by immunotherapy should be monitored. For the first objective, ana...

Full description

Bibliographic Details
Main Authors:	Takao Fujisawa, Mizuho Nagao, Yukiko Hiraguchi, Koa Hosoki, Reiko Tokuda, Satoko Usui, Sawako Masuda, Makito Shinoda, Akihiko Hashiguchi, Masao Yamaguchi
Format:	Article
Language:	English
Published:	Elsevier 2009-01-01
Series:	Allergology International
Subjects:	basophils CD203c cedar pollinosis IgG4 immunotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S1323893015306936

Similar Items

Staphylococcus aureus nasal colonization increases the risk of cedar pollinosis
by: Atsushi Morizane, et al.
Published: (2022-05-01)

Clinical aspects of Japanese cedar pollinosis
by: Minoru Okuda, et al.
Published: (1998-01-01)

Present Situation of Cedar Pollinosis in Japan and its Immune Responses
by: Yoshitaka Okamoto, et al.
Published: (2009-01-01)

Antigen-Induced Expression of CD203c on Basophils Predicts IgE-mediated Wheat Allergy
by: Reiko Tokuda, et al.
Published: (2009-01-01)

Complement Factor H Is an Early Predictive Biomarker of the Therapeutic Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis
by: Riyo Yoneda, et al.
Published: (2022-11-01)

Japanese cedar and cypress pollinosis updated: New allergens, cross-reactivity, and treatment
by: Toshihiro Osada, et al.
Published: (2021-07-01)

Effect of fexofenadine on the quality of life of Japanese cedar pollinosis patients
by: Kimihiro Okubo, et al.
Published: (2004-01-01)

The Relationship between Pollen Count Levels and Prevalence of Japanese Cedar Pollinosis in Northeast Japan
by: Kohei Honda, et al.
Published: (2013-01-01)

Sublingual Immunotherapy for Japanese Cedar Pollinosis: Current Clinical and Research Status
by: Daiju Sakurai, et al.
Published: (2022-11-01)

Solid-in-Oil Nanodispersions for Transcutaneous Immunotherapy of Japanese Cedar Pollinosis
by: Qingliang Kong, et al.
Published: (2020-03-01)

Association of Japanese cedar pollinosis and sensitization with HLA-DPB1 in the Japanese adolescent
by: Wataru Morii, et al.
Published: (2018-01-01)

Serum Concentrations of Antigen-Specific IgG4 in Patients with Japanese Cedar Pollinosis
by: Shiori Kitaya, et al.
Published: (2021-07-01)

Delay of Onset of Symptoms of Japanese Cedar Pollinosis by Treatment with a Leukotriene Receptor Antagonist
by: Minoru Gotoh, et al.
Published: (2011-01-01)

Effect of pollen exposure on serum IgE and IgG antibody responses in Japanese cedar pollinosis patients
by: Koichi Imaoka, et al.
Published: (1996-01-01)

Allergen‐specific subcutaneous immunotherapy for Japanese cedar pollinosis decreases the number of metachromatic cells and eosinophils in nasal swabs during the preseason and in season
by: Kuninori Otsuka, et al.
Published: (2020-09-01)

Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy
by: Kuninori Otsuka, et al.
Published: (2020-09-01)

Sublingual Immunotherapy for Japanese Cedar Pollinosis
by: Minoru Gotoh, et al.
Published: (2005-01-01)

Intake of a fermented plant product attenuates allergic symptoms without changing systemic immune responses in a mouse model of Japanese cedar pollinosis
by: Takashi Fujimura, et al.
Published: (2018-12-01)

Two Thirds of Forest Walkers with Japanese Cedar Pollinosis Visit Forests even During the Pollen Season
by: Emi Morita, et al.
Published: (2009-01-01)

The Differences in the Involvements of Loci of Promoter Region and Ile50Val in Interleukin-4 Receptor α Chain Gene between Atopic Dermatitis and Japanese Cedar Pollinosis
by: Takeshi Tanaka, et al.
Published: (2012-01-01)

Effect of intranasal corticosteroid on pre-onset activation of eosinophils and mast cells in experimental Japanese cedar pollinosis
by: Yasuyuki Noyama, et al.
Published: (2016-07-01)

'Benifuuki' Green Tea Containing O-Methylated Catechin Reduces Symptoms of Japanese Cedar Pollinosis: A Randomized, Double- Blind, Placebo-Controlled Trial
by: Sawako Masuda, et al.
Published: (2014-01-01)

Effect of concurrent administration of nobiletin and β-lactoglobulin on the symptoms of Japanese cedar pollinosis models in mice
by: Sho Yasunaga, et al.
Published: (2016-04-01)

Effect of birth season on allergic rhinitis and cedar pollinosis considering allergen and vitamin D exposure: The Japan Environment and Children's study (JECS)
by: Reiji Kojima, et al.
Published: (2023-07-01)

Sublingual Immunotherapy for Japanese Cedar Pollinosis
by: Kimihiro Okubo, et al.
Published: (2009-01-01)

Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy
by: Takashi Fujimura, et al.
Published: (2015-10-01)

The impact of co-existing seasonal allergic rhinitis caused by Japanese Cedar Pollinosis (SAR-JCP) upon asthma control status
by: Masayuki Hojo, et al.
Published: (2015-04-01)

Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen
by: Shoko Ueda, et al.
Published: (2022-03-01)

Measurement of Japanese Cedar Pollen-Specific IgE in Nasal Secretions
by: Hiroshi Sakaida, et al.
Published: (2014-01-01)

Early Interventional Treatment with Intranasal Mometasone Furoate in Japanese Cedar/Cypress Pollinosis: A Randomized Placebo-Controlled Trial
by: Seiichiro Makihara, et al.
Published: (2012-01-01)

Effect of Cry-consensus Peptide, a Novel Recombinant Peptide for Immunotherapy of Japanese Cedar Pollinosis, on an Experimental Allergic Rhinitis Model in B10.S Mice
by: Masako Tsunematsu, et al.
Published: (2007-01-01)

Effects of antihistamine on up-regulation of histamine H1 receptor mRNA in the nasal mucosa of patients with pollinosis induced by controlled cedar pollen challenge in an environmental exposure unit
by: Yoshiaki Kitamura, et al.
Published: (2015-11-01)

Relationship between Airborne Cry j 1 and the Onset Time of the Symptoms of Japanese Cedar Pollinosis Patients
by: Yuichi Takahashi, et al.
Published: (2007-01-01)

Cha o 3, a cypress pollen allergen, does not activate basophils in Japanese cypress pollinosis
by: Yoshiaki Kobayashi, MD, et al.
Published: (2024-02-01)

Allergic Potency of Japanese Cedar Pollen Cry j 1 Is Reduced by a Low Concentration of Hypochlorous Acid Generated by Electolysis
by: Tetsuya Terada, et al.
Published: (2009-01-01)

Continuous 6-Year Follow-Up Study of Sensitization to Japanese Cedar Pollen and Onset in Schoolchildren
by: Atsuko Kanazawa, et al.
Published: (2014-01-01)

Non-IgE,-IgG4 Antibody to Japanese Cedar Pollen Allergens:Comparison of Its Prevalence and Titers between Pollinosis Patients and Non-Patients
by: Hiroshi Miyazawa, et al.
Published: (2005-01-01)

Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: A prospective, randomized, open-label study
by: Daisuke Murakami, et al.
Published: (2015-04-01)

Japanese cedar pollen in floating indoor house dust after a pollinating season
by: Tadao Enomoto, et al.
Published: (2004-01-01)

Suppressive Effect of <em>Lactococcus lactis</em> subsp. <em>cremoris</em> YRC3780 on a Murine Model of Japanese Cedar Pollinosis
by: Kenji Uchida, et al.
Published: (2022-11-01)